Phenotypic Variability and Anticancer Alkaloid Profiles of Catharanthus roseus Cultivars Grown Under a Vertical Farming System

Plants are promising biofactories for high-value compounds, and integrating vertical farming (VF) with plant molecular farming (PMF) enhances the efficiency and sustainability of these systems. <i>Catharanthus roseus</i> (L.) is the only natural source of vinblastine (VLB) and vincristine (VCR), key anticancer alkaloids used in chemotherapy. This study assessed the morpho-physiological responses and the organ-specific anticancer-related terpenoid indole alkaloid (TIA) production in nine <i>C. roseus</i> cultivars grown in a VF system. Results revealed a significant intraspecific variability (between and within plant series) concerning both plant growth and alkaloid profile. Although total anticancer-related TIA concentration was 1.6- to 5.9-fold higher in leaves than in flowers, the key anticancer alkaloids VLB and VCR exhibited distinct patterns depending on the cultivar, with 'C-Red' showing a higher concentration of both alkaloids in leaves, while 'C-XDR-PN' and 'C-XDR-WT' had a significantly higher concentration of VCR in flowers (3.15 and 4.05-times higher, respectively). This cultivar-dependent variability, in the production of specific anticancer alkaloids, highlights the importance of a proper cultivar selection for their commercial production. Our findings show that VCR concentration may serve as a more reliable cultivar selection marker for anticancer alkaloid yield than total biomass or overall TIA content in VF systems.